AAAAAA

   
Results: 1-13 |
Results: 13
Mutation analysis of TP53 exons 5-8 by automated constant denaturant capillary electrophoresis
Authors: Bjorheim, J Gaudernack, G Ekstrom, PO
Citation: J. Bjorheim et al., Mutation analysis of TP53 exons 5-8 by automated constant denaturant capillary electrophoresis, TUMOR BIOL, 22(5), 2001, pp. 323-327
Successful induction of immune responses against mutant ras in melanoma patients using intradermal injection of peptides and GM-CSF as adjuvant
Authors: Hunger, RE Brand, CU Streit, M Eriksen, JA Gjertsen, MK Saeterdal, I Braathen, LR Gaudernack, G
Citation: Re. Hunger et al., Successful induction of immune responses against mutant ras in melanoma patients using intradermal injection of peptides and GM-CSF as adjuvant, EXP DERMATO, 10(3), 2001, pp. 161-167
Automated constant denaturant capillary electrophoresis applied for detection of KRAS exon 1 mutations
Authors: Bjorheim, J Ekstrom, PO Fossberg, E Borresen-Dale, AL Gaudernack, G
Citation: J. Bjorheim et al., Automated constant denaturant capillary electrophoresis applied for detection of KRAS exon 1 mutations, BIOTECHNIQU, 30(5), 2001, pp. 972-975
A TGF beta RII frameshift-mutation-derived CTL epitope recognised by HLA-A2-restricted CD8(+) T cells
Authors: Saeterdal, I Gjertsen, MK Straten, P Eriksen, JA Gaudernack, G
Citation: I. Saeterdal et al., A TGF beta RII frameshift-mutation-derived CTL epitope recognised by HLA-A2-restricted CD8(+) T cells, CANCER IMMU, 50(9), 2001, pp. 469-476
Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer
Authors: Saeterdal, I Bjorheim, J Lislerud, K Gjertsen, MK Bukholm, IK Olsen, OC Nesland, JM Eriksen, JA Moller, M Lindblom, A Gaudernack, G
Citation: I. Saeterdal et al., Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer, P NAS US, 98(23), 2001, pp. 13255-13260
Intradermal ras peptide vaccination with granulocyte-macrophage colony-stimulating factor as adjuvant: Clinical and immunological responses in patients with pancreatic adenocarcinoma
Authors: Gjertsen, MK Buanes, T Rosseland, AR Bakka, A Gladhaug, I Soreide, O Eriksen, JA Moller, M Baksaas, I Lothe, RA Saeterdal, I Gaudernack, G
Citation: Mk. Gjertsen et al., Intradermal ras peptide vaccination with granulocyte-macrophage colony-stimulating factor as adjuvant: Clinical and immunological responses in patients with pancreatic adenocarcinoma, INT J CANC, 92(3), 2001, pp. 441-450
Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study
Authors: Andreyev, HJN Norman, AR Cunningham, D Oates, J Dix, BR Iacopetta, BJ Young, J Walsh, T Ward, R Hawkins, N Beranek, M Jandik, P Benamouzig, R Jullian, E Laurent-Puig, P Olschwang, S Muller, O Hoffmann, I Rabes, HM Zietz, C Troungos, C Valavanis, C Yuen, ST Ho, JWC Croke, CT O'Donoghue, DP Giaretti, W Rapallo, A Russo, A Bazan, V Tanaka, M Omura, K Azuma, T Ohkusa, T Fujimori, T Ono, Y Pauly, M Faber, C Glaesener, R de Goeij, AFPM Arends, JW Andersen, SN Lovig, T Breivik, J Gaudernack, G Clausen, OPF De Angelis, P Meling, GI Rognum, TO Smith, R Goh, HS Font, A Rosell, R Sun, XF Zhang, H Benhattar, J Losi, L Lee, JQ Wang, ST Clarke, PA Bell, S Quirke, P Bubb, VJ Piris, J Cruickshank, NR Morton, D Fox, JC Al-Mulla, F Lees, N Hall, CN Snary, D Wilkinson, K Dillon, D Costa, J Pricolo, VE Finkelstein, SD Thebo, JS Senagore, AJ Halter, SA Wadler, S Malik, S Krtolica, K Urosevic, N
Citation: Hjn. Andreyev et al., Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study, BR J CANC, 85(5), 2001, pp. 692-696
Identification of nucleolar protein No55 as a tumour-associated autoantigen in patients with prostate cancer
Authors: Fossa, A Siebert, R Aasheim, HC Maelandsmo, GM Berner, A Fossa, SD Paus, E Smeland, EB Gaudernack, G
Citation: A. Fossa et al., Identification of nucleolar protein No55 as a tumour-associated autoantigen in patients with prostate cancer, BR J CANC, 83(6), 2000, pp. 743-749
Genomic instability, DNA methylation, and natural selection in colorectal carcinogenesis
Authors: Breivik, J Gaudernack, G
Citation: J. Breivik et G. Gaudernack, Genomic instability, DNA methylation, and natural selection in colorectal carcinogenesis, SEM CANC B, 9(4), 1999, pp. 245-254
Combination of GM-CSF with antitumour vaccine strategies
Authors: Gaudernack, G Gjertsen, MK
Citation: G. Gaudernack et Mk. Gjertsen, Combination of GM-CSF with antitumour vaccine strategies, EUR J CANC, 35, 1999, pp. S33-S35
Carcinogenesis and natural selection: A new perspective to the genetics and epigenetics of colorectal cancer
Authors: Breivik, J Gaudernack, G
Citation: J. Breivik et G. Gaudernack, Carcinogenesis and natural selection: A new perspective to the genetics and epigenetics of colorectal cancer, ADV CANC R, 76, 1999, pp. 187
Culture characterization of differentiated high endothelial venule cells from human tonsils
Authors: Baekkevold, ES Jahnsen, FL Johansen, FE Bakke, O Gaudernack, G Brandtzaeg, P Haraldsen, G
Citation: Es. Baekkevold et al., Culture characterization of differentiated high endothelial venule cells from human tonsils, LAB INV, 79(3), 1999, pp. 327-336
Photochemical internalization: A novel technology for delivery of macromolecules into cytosol
Authors: Berg, K Selbo, PK Prasmickaite, L Tjelle, TE Sandvig, K Moan, D Gaudernack, G Fodstad, O Kjolsrud, S Anholt, H Rodal, GH Rodal, SK Hogset, A
Citation: K. Berg et al., Photochemical internalization: A novel technology for delivery of macromolecules into cytosol, CANCER RES, 59(6), 1999, pp. 1180-1183
Risultati: 1-13 |